Page last updated: 2024-09-02

hydroxyitraconazole and AIDS-Related Opportunistic Infections

hydroxyitraconazole has been researched along with AIDS-Related Opportunistic Infections in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beijnen, JH; Crommentuyn, KM; Huitema, AD; Mulder, JW; Schellens, JH; Sparidans, RW	1
Ajana, F; Bazin, C; Chwetzoff, E; Datry, A; Le Moing, JP; Levron, JC; Reynes, J	1
Cartledge, JD; Gazzard, BG; Midgely, J	1

Trials

1 trial(s) available for hydroxyitraconazole and AIDS-Related Opportunistic Infections

Article	Year
Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:11 Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Area Under Curve; Biological Availability; Candidiasis, Oral; Chromatography, High Pressure Liquid; Female; Humans; Itraconazole; Male; Middle Aged; Saliva	1997

Article

Year

Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis.

Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:11

Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Area Under Curve; Biological Availability; Candidiasis, Oral; Chromatography, High Pressure Liquid; Female; Humans; Itraconazole; Male; Middle Aged; Saliva

1997

Other Studies

2 other study(ies) available for hydroxyitraconazole and AIDS-Related Opportunistic Infections

Article	Year
Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Apr-15, Volume: 38, Issue:8 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Drug Therapy, Combination; Histoplasmosis; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir	2004
Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. Journal of clinical pathology, 1997, Volume: 50, Issue:6 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Capsules; Chemistry, Pharmaceutical; Cohort Studies; Humans; Itraconazole; Male; Solutions	1997

Article

Year

Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Apr-15, Volume: 38, Issue:8

Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Drug Therapy, Combination; Histoplasmosis; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir

2004

Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.

Journal of clinical pathology, 1997, Volume: 50, Issue:6

Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Capsules; Chemistry, Pharmaceutical; Cohort Studies; Humans; Itraconazole; Male; Solutions

1997